Actuate Therapeutics ACTU
NASDAQ ACTU
$0.58 -0.03 (-5.10%)
As of: Oct 21, 2026 · 1:52 PM EDT

Actuate Therapeutics (ACTU) Interest Paid (2024 - 2025)

Updated

Analysis

Actuate Therapeutics (ACTU) Interest Paid (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn -
2 Johnson & Johnson 616.05 Bn 534.58 Bn 17.26 Bn -
3 AbbVie 500.90 Bn 474.01 Bn 12.70 Bn -
4 Merck 367.17 Bn 321.54 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 1.07 Bn
7 Amgen 235.77 Bn 191.17 Bn 7.24 Bn -
8 Gilead Sciences 190.70 Bn 164.90 Bn 6.22 Bn -
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn 1.25 Bn
10 Actuate Therapeutics 13.77 Mn -27.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 70,957.00
Sep 30, 2024 71,033.00
API Access

Actuate Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=ACTU&period=max&api_key=YOUR_API_KEY